Trinity Biotech plc (NASDAQ: TRIB) saw a big move last session, as the company's shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $25.61 to $27.81 in the past one-month time frame.
This slump shouldn't be too much of a surprise to investors, as the company has seen 1 negative revisions in the past few weeks and its current year earnings consensus has moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.
TRIB currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Some better-ranked stocks in the same sector include Siemens Baxter Inernational Inc. (NYSE: BAX), Covidien plc (NYSE: COV) and Meridian Bioscience, Inc. (NASDAQ: VIVO). All these stocks hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
BAXTER INTL (NYSE: BAX): Free Stock Analysis Report
COVIDIEN PLC (NYSE: COV): Free Stock Analysis Report
TRINITY BIOTECH (NASDAQ: TRIB): Free Stock Analysis Report
MERIDIAN BIOSCI (NASDAQ: VIVO): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research